Does segmentectomy really preserve the pulmonary function better than lobectomy for patients with early-stage lung cancer? 2017

Hidemi Suzuki, and Junichi Morimoto, and Teruaki Mizobuchi, and Taiki Fujiwara, and Kaoru Nagato, and Takahiro Nakajima, and Takekazu Iwata, and Shigetoshi Yoshida, and Ichiro Yoshino
Department of General Thoracic Surgery, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan. hidemisuzukidesu@yahoo.co.jp.

OBJECTIVE Recently, segmentectomy has been considered as an alternative to lobectomy in early peripheral non-small lung cancer (NSCLC); however, controversy has remained regarding the long-term functional advantage after segmentectomy. The aim of this study was to analyze the postoperative lung function after segmentectomy and lobectomy for non-small cell lung cancer. METHODS Patients with p-T1aN0M0 NSCLC who had undergone segmentectomy (n = 37) or lobectomy (n = 33) were retrospectively analyzed. The ratios of postoperative to preoperative forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1) were defined as the recovery rates. The radiological lung volume and weight were evaluated before and more than 6 months after surgery, and the postoperative values were compared with the predicted values that were calculated from the preoperative values, subtracting the resected lobes or segments. RESULTS The clinical characteristics, including the preoperative lung function showed no significant differences between the groups. No statistical differences were recognized in the trend lines for recovery ratios of FVC and FEV1.0 (P = 0.96 and P = 0.33). The recovery ratios for radiologic lung volume and weight showed no significant differences (P = 0.46 and P = 0.22). The postoperative lung volume and weight were almost the same as the predicted values after segmentectomy, whereas those after lobectomy were significantly higher than the predicted values. CONCLUSIONS No functional advantage for segmentectomy was observed during long-term follow-up, possibly due to compensatory lung growth after lobectomy.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011013 Pneumonectomy The excision of lung tissue including partial or total lung lobectomy. Bronchoscopic Lung Volume Reduction,Endoscopic Lung Volume Reduction,Lung Volume Reduction,Lung Volume Reduction Surgery,Partial Pneumonectomy,Partial Pneumonectomies,Pneumonectomies,Pneumonectomy, Partial,Reduction, Lung Volume,Volume Reduction, Lung
D012129 Respiratory Function Tests Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc. Lung Function Tests,Pulmonary Function Tests,Function Test, Pulmonary,Function Tests, Pulmonary,Pulmonary Function Test,Test, Pulmonary Function,Tests, Pulmonary Function,Function Test, Lung,Function Test, Respiratory,Function Tests, Lung,Function Tests, Respiratory,Lung Function Test,Respiratory Function Test,Test, Lung Function,Test, Respiratory Function,Tests, Lung Function,Tests, Respiratory Function
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory

Related Publications

Hidemi Suzuki, and Junichi Morimoto, and Teruaki Mizobuchi, and Taiki Fujiwara, and Kaoru Nagato, and Takahiro Nakajima, and Takekazu Iwata, and Shigetoshi Yoshida, and Ichiro Yoshino
February 2023, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
Hidemi Suzuki, and Junichi Morimoto, and Teruaki Mizobuchi, and Taiki Fujiwara, and Kaoru Nagato, and Takahiro Nakajima, and Takekazu Iwata, and Shigetoshi Yoshida, and Ichiro Yoshino
July 2018, Journal of thoracic disease,
Hidemi Suzuki, and Junichi Morimoto, and Teruaki Mizobuchi, and Taiki Fujiwara, and Kaoru Nagato, and Takahiro Nakajima, and Takekazu Iwata, and Shigetoshi Yoshida, and Ichiro Yoshino
September 2021, The Journal of international medical research,
Hidemi Suzuki, and Junichi Morimoto, and Teruaki Mizobuchi, and Taiki Fujiwara, and Kaoru Nagato, and Takahiro Nakajima, and Takekazu Iwata, and Shigetoshi Yoshida, and Ichiro Yoshino
August 2014, World journal of surgery,
Hidemi Suzuki, and Junichi Morimoto, and Teruaki Mizobuchi, and Taiki Fujiwara, and Kaoru Nagato, and Takahiro Nakajima, and Takekazu Iwata, and Shigetoshi Yoshida, and Ichiro Yoshino
April 2016, Oncotarget,
Hidemi Suzuki, and Junichi Morimoto, and Teruaki Mizobuchi, and Taiki Fujiwara, and Kaoru Nagato, and Takahiro Nakajima, and Takekazu Iwata, and Shigetoshi Yoshida, and Ichiro Yoshino
January 2022, Evidence-based complementary and alternative medicine : eCAM,
Hidemi Suzuki, and Junichi Morimoto, and Teruaki Mizobuchi, and Taiki Fujiwara, and Kaoru Nagato, and Takahiro Nakajima, and Takekazu Iwata, and Shigetoshi Yoshida, and Ichiro Yoshino
November 2021, Translational lung cancer research,
Hidemi Suzuki, and Junichi Morimoto, and Teruaki Mizobuchi, and Taiki Fujiwara, and Kaoru Nagato, and Takahiro Nakajima, and Takekazu Iwata, and Shigetoshi Yoshida, and Ichiro Yoshino
July 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
Hidemi Suzuki, and Junichi Morimoto, and Teruaki Mizobuchi, and Taiki Fujiwara, and Kaoru Nagato, and Takahiro Nakajima, and Takekazu Iwata, and Shigetoshi Yoshida, and Ichiro Yoshino
January 2023, Evidence-based complementary and alternative medicine : eCAM,
Hidemi Suzuki, and Junichi Morimoto, and Teruaki Mizobuchi, and Taiki Fujiwara, and Kaoru Nagato, and Takahiro Nakajima, and Takekazu Iwata, and Shigetoshi Yoshida, and Ichiro Yoshino
December 2022, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
Copied contents to your clipboard!